HDAC11 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
Mocetinostat (CAS 726169-73-9) is a chemical compound that functions as an inhibitor of HDAC11, a specific histone deacetylase enzyme. Its molecular properties enable it to selectively target and block HDAC11 activity, potentially impacting cellular processes and gene expression regulation. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
JNJ-26481585 (CAS 875320-29-9) is a chemical compound known for its function as an inhibitor of HDAC11, a specific histone deacetylase enzyme. It modulates HDAC11 activity, affecting epigenetic processes within a research lab setting. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $63.00 $179.00 | 11 | |
Scriptaid is an HDAC inhibitor that has been reported to inhibit HDAC11 along with other HDAC family members. It was originally identified as an enhancer of the reprogramming of somatic cells into induced pluripotent stem cells. | ||||||
PI3K/HDAC Inhibitor | 1339928-25-4 | sc-364584 sc-364584A | 5 mg 10 mg | $340.00 $462.00 | ||
The chemical "PI3K/HDAC Inhibitor" (CAS 1339928-25-4) is a compound known for its inhibitory action specifically targeting HDAC11, a histone deacetylase enzyme. By selectively inhibiting HDAC11, it modulates cellular acetylation processes, which can have various effects on cellular functions. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat is a pan-HDAC inhibitor that has been studies for its potential myeloma fighting properties. While it primarily targets HDACs 1, 2, 3, and 6, it may also have some effect on HDAC11. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
Belinostat is a pan-HDAC inhibitor that has been studies for its potential peripheral T-cell lymphoma fighting properties. It primarily targets HDACs 1, 2, 3, and 6 but may also have effects on HDAC11. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid is an approved drug used for epilepsy and bipolar disorder. It is also known to have HDAC inhibitory activity, including some effect on HDAC11. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Entinostat is a selective inhibitor of HDAC1 and HDAC3. It has been tested in research trials for various cancer therapies. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is a pan-HDAC inhibitor which targets HDACs 1, 2, 3, and 6, and may also inhibit HDAC11 to some extent. | ||||||
ITF2357 | 732302-99-7 | sc-364513 sc-364513A | 5 mg 50 mg | $340.00 $1950.00 | ||
Givinostat is a potent pan-HDAC inhibitor with therapeutic potential in various inflammatory and autoimmune diseases. It targets multiple HDAC family members, including HDAC11. | ||||||